FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Adapalene/Benzoyl Peroxide Topical Gel
Status: Discontinuation
»Therapeutic Categories: Dermatology

Teva Pharmaceuticals (New 01/27/2021)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
0.1/2.5% PMP 45 g (NDC 0472-0310-38) 01/27/2021 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English